Objective: The Visual Prostate Symptom Score (VPSS) is a simple tool developed to evaluate lower urinary tract symptoms (LUTS), particularly in individuals with low educational levels. This study investigated the relationship between the urinary stream image in the first question of the VPSS and the maximum urinary flow rate (Qmax). The aim was to estimate Qmax in patients unable to undergo testing and to reduce unnecessary uroflowmetry procedures. Material and Methods: A total of 93 patients over the age of 40 who had completed the VPSS form and undergone at least two uroflowmetry tests were included. Patients with diabetes, neurological diseases, a history of prostate or urethral surgery, and those with a voided urine volume of less than 150 mL were excluded. Based on the image in the first VPSS question, patients were divided into five groups. The relationship between this image and Qmax was analyzed using Pearson correlation. Variables such as age, voided volume, and presence of a median lobe were evaluated using multivariate regression analysis. Results: A strong negative correlation was found between the first VPSS question and Qmax (r=-0.942, p<0.001). While Qmax was within normal limits in the first two groups (24.33 mL/s and 16.21 mL/s), it was lower in the fourth and fifth groups (7.26 mL/s and 5.22 mL/s). The third group fell within a gray zone (11.11 mL/s). Conclusion: The urinary stream image in the VPSS shows a significant correlation with Qmax and may serve as a practical evaluation tool, especially in patients who are unable to undergo uroflowmetry.
Keywords: International Prostate Symptom Score; Visual Prostate Symptom Score; uroflowmetry
Amaç: Görsel Prostat Semptom Skoru (GPSS), özellikle düşük eğitim düzeyine sahip bireylerde alt üriner sistem semptomlarını değerlendirmek için geliştirilmiş basit bir ölçektir. Bu çalışmada, GPSS'nin birinci sorusundaki idrar akım görseli ile maksimum idrar akış hızı (Qmax) arasındaki ilişki araştırılmıştır. Amaç, test yapılamayan hastalarda Qmax hakkında öngörü sağlamak ve gereksiz üroflowmetri testlerini azaltmaktır. Gereç ve Yöntemler: VPSS formunu doldurmuş ve en az iki kez üroflowmetri uygulanmış, 40 yaş üzeri 93 hasta incelendi. Diyabet, nörolojik hastalık, prostat/üretra cerrahisi öyküsü olanlar ve idrar hacmi <150 mL olanlar dışlandı. VPSS'nin birinci sorusundaki görsele göre hastalar 5 gruba ayrıldı ve görsel ile Qmax arasındaki ilişki Pearson korelasyon analizi ile değerlendirildi. Yaş, işeme hacmi ve median lob varlığı gibi değişkenler çok değişkenli regresyon ile analiz edildi. Bulgular: VPSS'nin birinci sorusu ile Qmax arasında güçlü bir negatif korelasyon saptandı (r=-0,942, p<0,001). İlk iki grupta Qmax normal düzeyde iken (24,33 mL/sn ve 16,21 mL/sn), dördüncü ve beşinci gruplarda düşüktü (7,26 mL/sn ve 5,22 mL/sn). Üçüncü grup gri bölgede yer almaktaydı (11,11 mL/sn). Sonuç: GPSS'nin idrar akış görseli, Qmax ile anlamlı ilişki göstermekte olup, özellikle üroflowmetri yapılamayan hastalarda pratik bir değerlendirme aracı olarak kullanılabilir.
Anahtar Kelimeler: Uluslararası Prostat Semptom Skoru; Görsel Prostat Semptom Skoru; üroflowmetri
- Avasarala KA, Ahmed SM, Nandagiri S, Tadisetty S. Epidemiological differences of lower urinary tract symptoms among female subpopulations and group level interventions. Indian J Urol. 2008;24(4):498-503. [Crossref] [PubMed] [PMC]
- Martin SA, Haren MT, Marshall VR, Lange K, Wittert GA; Members of the Florey Adelaide Male Ageing Study. Prevalence and factors associated with uncomplicated storage and voiding lower urinary tract symptoms in community-dwelling Australian men. World J Urol. 2011;29(2):179-84. [PubMed]
- Berghmans LC, Hendriks HJ, Bo K, Hay-Smith EJ, de Bie RA, van Waalwijk van Doorn ES. Conservative treatment of stress urinary incontinence in women: a systematic review of randomized clinical trials. Br J Urol. 1998;82(2):181-91. [Crossref] [PubMed]
- Oelke M, Bachmann A, Descazeaud A, Emberton M, Gravas S, Michel MC, et al; European Association of Urology. EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol. 2013;64(1):118-40. [PubMed]
- Wadie BS, Badawi AM, Ghoneim MA. The relationship of the International Prostate Symptom Score and objective parameters for diagnosing bladder outlet obstruction. Part II: the potential usefulness of artificial neural networks. J Urol. 2001;165(1):35-7. [PubMed]
- Bosch JL, Hop WC, Kirkels WJ, Schröder FH. The International Prostate Symptom Score in a community-based sample of men between 55 and 74 years of age: prevalence and correlation of symptoms with age, prostate volume, flow rate and residual urine volume. Br J Urol. 1995;75(5):622-30. [PubMed]
- Eckhardt MD, van Venrooij GE, Boon TA. Symptoms and quality of life versus age, prostate volume, and urodynamic parameters in 565 strictly selected men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Urology. 2001;57(4):695-700. [PubMed]
- Lukacs B, Grange JC, Comet D. One-year follow-up of 2829 patients with moderate to severe lower urinary tract symptoms treated with alfuzosin in general practice according to IPSS and a health-related quality-of-life questionnaire. BPM Group in General Practice. Urology. 2000;55(4):540-6. [PubMed]
- Johnson TV, Abbasi A, Ehrlich SS, Kleris RS, Schoenberg ED, Owen-Smith A, et al. Patient misunderstanding of the individual questions of the American Urological Association symptom score. J Urol. 2008;179(6):2291-4; discussion 2294-5. [PubMed]
- van der Walt CL, Heyns CF, Groeneveld AE, Edlin RS, van Vuuren SP. Prospective comparison of a new visual prostate symptom score versus the international prostate symptom score in men with lower urinary tract symptoms. Urology. 2011;78(1):17-20. [PubMed]
- Wessels SG, Heyns CF. Prospective evaluation of a new visual prostate symptom score, the international prostate symptom score, and uroflowmetry in men with urethral stricture disease. Urology. 2014;83(1):220-4. [PubMed]
- Park YW, Lee JH. Correlation between the visual prostate symptom score and international prostate symptom score in patients with lower urinary tract symptoms. Int Neurourol J. 2014;18(1):37-41. . [Crossref] [PubMed] [PMC]
- Selekman RE, Harris CR, Filippou P, Chi T, Alwaal A, Blaschko SD, et al. Validation of a Visual Prostate Symptom Score in Men With Lower Urinary Tract Symptoms in a Health Safety Net Hospital. Urology. 2015;86(2):354-8. . [Crossref] [PubMed] [PMC]
- MacDiarmid SA, Goodson TC, Holmes TM, Martin PR, Doyle RB. An assessment of the comprehension of the American Urological Association Symptom Index. J Urol. 1998;159(3):873-4. [PubMed]
- Netto Júnior NR, de Lima ML. The influence of patient education level on the International Prostatic Symptom Score. J Urol. 1995;154(1):97-9. [Crossref]
.: Process List